Purification, cloning and expression of dehydroascorbic acid-reducing activity from human neutrophils: Identification as glutaredoxin

被引:100
作者
Park, JB [1 ]
Levine, M [1 ]
机构
[1] NIDDK,CELL BIOL & GENET LAB,NIH,BETHESDA,MD 20892
关键词
D O I
10.1042/bj3150931
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dehydroascorbic acid-reducing activity in normal human neutrophil lysates was characterized and identified by activity-based purification and measurement of newly synthesized ascorbate by HPLC. The initial reducing activity was non-dialysable and could not be accounted for by the activity of glutathione as a reducing agent. The reducing activity was purified to homogeneity as an 11 kDa protein. The protein had a specific activity of 3 mu mol/min per mg of protein and was glutathione dependent. Kinetic experiments showed that the protein had a K-m for glutathione of 2.0 mM and a K-m for dehydroascorbic acid of 250 mu M. Dehydroascorbic acid reduction by the purified protein was pH dependent and was maximal at pH 7.5. Peptide fragments from the purified protein were analysed for amino acid sequence and the protein was identified as glutaredoxin. By using degenerate oligonucleotides based on the amino acid sequence, glutaredoxin was cloned from a human neutrophil library. Expressed purified glutaredoxin displayed reducing activity and kinetics that were indistinguishable from those of native purified enzyme. Several approaches indicated that glutaredoxin was responsible for the most of the protein-mediated dehydroascorbic acid reduction in lysates. From protein purification data, glutaredoxin was responsible for at least 47% of the initial reducing activity. Dehydroascorbic acid reduction was at least 5-fold greater in neutrophil lysates than in myeloid tumour cell lysates, and glutaredoxin was detected in normal neutrophil lysates but not in myeloid tumour cell lysates by Western blotting. Glutaredoxin inhibitors inhibited dehydroascorbic acid reduction in neutrophil lysates as much as 80%. These findings indicate that glutaredoxin plays a major role in dehydroascorbic acid reduction in normal human neutrophil lysates, and represent the first identification of dehydroascorbic acid reductase in human tissue by activity-based purification.
引用
收藏
页码:931 / 938
页数:8
相关论文
共 37 条
  • [1] HUMAN CELL DEHYDROASCORBATE REDUCTASE KINETIC AND FUNCTIONAL-PROPERTIES
    BIGLEY, R
    RIDDLE, M
    LAYMAN, D
    STANKOVA, L
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 659 (01) : 15 - 22
  • [2] INTERACTION BETWEEN GLUCOSE AND DEHYDROASCORBATE TRANSPORT IN HUMAN-NEUTROPHILS AND FIBROBLASTS
    BIGLEY, R
    WIRTH, M
    LAYMAN, D
    RIDDLE, M
    STANKOVA, L
    [J]. DIABETES, 1983, 32 (06) : 545 - 548
  • [3] ENZYMATIC BASIS FOR ALTERED ASCORBIC-ACID AND DEHYDROASCORBIC ACID LEVELS IN DIABETES
    BODE, AM
    YAVAROW, CR
    FRY, DA
    VARGAS, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (03) : 1347 - 1353
  • [4] ASCORBIC-ACID REGENERATION BY BOVINE IRIS-CILIARY BODY
    BODE, AM
    GREEN, E
    YAVAROW, CR
    WHEELDON, SL
    BOLKEN, S
    GOMEZ, Y
    ROSE, RC
    [J]. CURRENT EYE RESEARCH, 1993, 12 (07) : 593 - 601
  • [5] BODE AM, 1991, INVEST OPHTH VIS SCI, V32, P2266
  • [6] Borsook H, 1937, J BIOL CHEM, V117, P237
  • [7] BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
  • [8] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [9] ENZYMATIC RECYCLING OF OXIDIZED ASCORBATE IN PIG-HEART - ONE-ELECTRON VS 2-ELECTRON PATHWAY
    COASSIN, M
    TOMASI, A
    VANNINI, V
    URSINI, F
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 290 (02) : 458 - 462
  • [10] EXPRESSION OF A RABBIT RENAL ASCORBIC-ACID TRANSPORTER IN XENOPUS-LAEVIS OOCYTES
    DYER, DL
    KANAI, Y
    HEDIGER, MA
    RUBIN, SA
    SAID, HM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (01): : C301 - C306